Vimeo
LinkedIn
Instagram
Share |

Indian businesses

August 30, 2011

Family-controlled Indian conglomerate Piramal Group plans to make a big investment internationally as it seeks growth outside of its home market.

Family-controlled Indian conglomerate Piramal Group plans to make a big investment internationally as it seeks growth outside of its home market.

A spokesman for the company, which operates in a number of areas including pharmaceuticals, real estate and healthcare, told CampdenFB that the Piramal family will invest around $1.5 billion in mostly biotech companies in the US and Europe.

“The investment is part of our ongoing strategic diversification efforts,” he said.

Click here >>
Close